Bank of America
DOVA

Bank of America’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bank of America’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-31,971
Closed -$894K – 7687
2019
Q3 		$894K Buy
31,971
+13,531
+73% +$219K ﹤0.01% 4630
2019
Q2 		$260K Buy
18,440
+10,145
+122% +$96.5K ﹤0.01% 5482
2019
Q1 		$74K Sell
8,295
-1,775
-18% -$14.4K ﹤0.01% 6032
2018
Q4 		$77K Sell
10,070
-928
-8% -$14.9K ﹤0.01% 6047
2018
Q3 		$231K Buy
10,998
+5,693
+107% +$136K ﹤0.01% 5413
2018
Q2 		$159K Buy
5,305
+2,379
+81% +$64.8K ﹤0.01% 5543
2018
Q1 		$79K Sell
2,926
-1,628
-36% -$48.7K ﹤0.01% 5850
2017
Q4 		$131K Buy
4,554
+4,314
+1,798% +$118K ﹤0.01% 5618
2017
Q3 		$6K Buy
+240
New +$5.69K ﹤0.01% 6701

Bank of America's DOVA Position: Q4 2019 in Review

Bank of America sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 31,971 shares — an estimated $894K sold.

Bank of America first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $894K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Bank of America reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Bank of America sold 31,971 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $894K.
  • Bank of America first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
  • Bank of America's Dova Pharmaceuticals, Inc. Common Stock position peaked at $894K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.